(including messenger RNAs (mRNA) and microRNAs (miRNA) [5] . 42 A growing body of research into stem cell therapy has revealed that the mode of action 43 underlying the therapeutic effects of stem cells occurs largely via paracrine signaling [14]- 44 [17]. This understanding has evolved based on the fact that implanted cells do not often 45 engraft or persist long-term, but rather, generate paracrine effects, which can be mediated 46 by exosomes transmitting information into resident tissue cells. Indeed, post-injury tissue 47 regeneration studies have revealed that the regenerative effect of exosomes can be as potent 48 as that of parent cells in promoting regeneration and functional recovery in experimental 
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There is widespread consensus that EVs have a biologic signature that reflects the phenotype 59 of the cells that produced them [21] . For this reason, the potential applications of EVs in a 60 clinical context are diverse. 61 On the one hand, EVs have been proposed as diagnostic biomarkers of disease in cancers as 62 diverse as ovarian cancer [22] , [23] , glioblastoma [19] , melanoma [24] prostate cancer [25] 63 and colon cancer [26] , based on unique miRNA profiles and other cargo that is transmitted 64 with pathological effect. Similarly, they might be used as biomarkers of infectious disease, 65 based on that fact that they transmit infection-specific elements. For example, exosomes 66 isolated from Huh 7.5 cell lines infected with Hepatitis C virus have been reported to infect 67 primary human hepatocytes [27] . 68 On the other hand, they can also act as potent mediators of cell signaling, which might be [50] ; an example of this heterogeneity was shown in a study 154 conducted on between dendritic cell derived apoptotic vesicles and exosomes, that exosomal 155 fractions had their own unique molecular composition and properties [51] . They might even 156 induce undesirable cell signaling events, although this warrants further investigation.
157
As cells produce and secrete exosomes naturally, perfusion-based cultures (for example using 158 hollow-fiber and packed bed technologies), should also be considered with the aim of 159 providing adequate mass transfer in the cell culture. A key practical benefit in this approach 160 is that these reactor systems can be designed and optimized to retain the exosome product 
